DCOY — Decoy Therapeutics Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1615219 ·
Last close
$3.09
Market Cap
$2.02M
52W High
$55.92
52W Low
$2.18
ADV30
4,487,937
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -2,403,392 | -2,373,800 | 9,001,160 | 8,289,108 | 4,680,254 |
| Mar 2026 | 0 | — | -2,283,739 | -2,224,628 | 8,423,275 | 7,820,608 | 4,545,890 |
| Dec 2025 | 0 | — | -9,034,562 | -8,977,655 | 11,056,707 | 10,709,937 | 5,167,738 |
| Sep 2025 | 0 | — | -895,130 | -873,467 | 6,097,032 | 4,809,680 | 1,848,967 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,534,803
Investing CF
$964,735
Financing CF
$11,792,296
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-346.97
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-96,666,726
Inventory
—
Receivables
$200,000
ST Investments
—
EBIT TTM
$-13,178,996
Pretax Income TTM
$-13,033,575
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$227,629
EBITDA
$-6,074,362
Free Cash Flow
$-509,881
Enterprise Value
$-6,539,764
Total Cash
$8,289,108
Total Debt
$0
Shares Out
655,185
Trailing EPS
$115.98
Book Value
$8.12
ROE
-827.8%
ROA
-73.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -12,613,952 | -12,518,480 | 11,056,707 | 5,167,738 | 5,888,969 | -4,827,188 |
| Dec 2024 | 0 | -5,734,316 | -5,575,777 | 3,022,974 | 1,511,279 | 1,511,695 | -4,525,337 |
| Dec 2023 | 0 | -12,894,944 | -12,542,693 | 6,586,523 | 1,299,241 | 5,287,282 | -12,846,137 |
| Dec 2022 | 0 | -22,975,231 | -31,607,956 | 14,650,799 | 4,266,191 | 10,384,608 | -17,595,321 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-21,561,494
OpCashFlow TTM
$0
Assets (Latest)
$3,022,974
Forward EPS
$-19.32
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACUT | Accustem Sciences Inc. | $1.93M | $0.12 | — |
| NXTS | Nexentis Technologies Inc. | $2.14M | $1.47 | — |
| PCYN | PROCYON CORP | $2.20M | $0.27 | — |
| OGEN | ORAGENICS INC | $2.21M | $0.49 | — |
| CVSI | CV Sciences, Inc. | $2.26M | $0.01 | — |
News headlines (Yahoo Finance, 1h cache)
Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
2026-09-22 22:14 · Yahoo
/C O R R E C T I O N -- Decoy Therapeutics, Inc/
2026-09-22 18:03 · Yahoo
Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding
2026-09-22 11:30 · Yahoo
Decoy Therapeutics to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
2026-09-08 13:00 · Yahoo
Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors
2026-07-15 13:24 · Yahoo
DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally?
2026-06-29 15:41 · Yahoo
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
2026-06-27 00:11 · Yahoo
Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
2026-06-08 12:00 · Yahoo
Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors
2026-06-03 12:00 · Yahoo
Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board
2026-05-26 12:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.